Literature DB >> 5703635

Clinical and metabolic effects of different doses of prostaglandin E1 in man. Prostaglandin and related factors.

L A Carlson, L G Ekelund, L Orö.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5703635     DOI: 10.1111/j.0954-6820.1968.tb10502.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  15 in total

Review 1.  Prostaglandins and the gastrointestinal tract.

Authors:  S L Waller
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

2.  The relationship between functional vasodilatation in adipose tissue and prostaglandin.

Authors:  N G Bowery; G P Lewis; J Matthews
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

Review 3.  Current concepts in the pathogenesis and interval treatment of migraine.

Authors:  M Anthony; J W Lance
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  Effect of prostaglandin E 1 on cerebral circulatory disturbances following subarachnoid haemorrage in man.

Authors:  L Steiner; D M Forster; U Bergvall; L A Carlson
Journal:  Neuroradiology       Date:  1972-06       Impact factor: 2.804

5.  Some effects of prostaglandins in man.

Authors:  J J Misiewicz
Journal:  Proc R Soc Med       Date:  1971-01

Review 6.  Prostaglandins: a report on early clinical studies.

Authors:  J W Hinman
Journal:  Postgrad Med J       Date:  1970-09       Impact factor: 2.401

7.  Prostaglandin E1 for alleviating symptoms of ergot intoxication: a case report.

Authors:  J M Levy; F Ibrahim; P W Nykamp; D E Weiland
Journal:  Cardiovasc Intervent Radiol       Date:  1984       Impact factor: 2.740

Review 8.  Menstrual migraine: a review of prophylactic therapies.

Authors:  Vincent T Martin
Journal:  Curr Pain Headache Rep       Date:  2004-06

Review 9.  Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

10.  EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.

Authors:  Richard J Davis; Colin E Murdoch; Mozam Ali; Stuart Purbrick; Rivka Ravid; Gordon S Baxter; Nick Tilford; Robert L G Sheldrick; Kenneth L Clark; Robert A Coleman
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.